|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/138 | |
| A61K 31/343 | |||
| A61K 31/704 | |||
| A61K 33/24 | |||
| A61P 35/00 |
| (11) | Number of the document | 2753322 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12769146.7 |
| Date of filing the European patent application | 2012-09-07 | |
| (97) | Date of publication of the European application | 2014-07-16 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/FR2012/052004 |
| Date | 2012-09-07 |
| (87) | Number | WO 2013/034863 |
| Date | 2013-03-14 |
| (30) | Number | Date | Country code |
| 1102727 | 2011-09-08 | FR | |
| 201161573585 P | 2011-09-08 | US |
| (72) |
KLOOS, Ioana, FR
ROBERT, Renata, FR
JACQUET-BESCOND, Anne, FR
DEPIL, Stéphane, FR
CHENEL, Marylore, FR
FOULIARD, Sylvain, FR
BALASUBRAMANIAN, Sriram, US
|
| (73) |
Pharmacyclics, Inc.,
995 East Arques Avenue, Sunnyvale, CA 94085,
US
|
| (54) | SCHEMA D`ADMINISTRATION DU N-HYDROXY-4-{2-[3-(N,N-DIMETHYLAMINOMETHYL)BENZOFURAN-2-YLCARBONYLAMINO]ETHOXY}BENZAMIDE |
| DOSAGE REGIMEN OF N-HYDROXY-4-{2-[3-(N,N-DIMETHYLAMINOMETHYL)BENZOFURAN-2-YLCARBONYLAMINO]ETHOXY}BENZAMIDE |